In the long human struggle against metabolic disease, most interventions have worked by quieting hunger — but a team at UC Berkeley has turned toward a different question: what if the body could simply be asked to burn more? Their compound, TOFA, appears to do precisely that in animal studies, increasing cellular energy expenditure, preserving muscle, and improving insulin sensitivity without the nutritional costs that shadow appetite-suppressing drugs. It is early, uncertain, and untested in humans — and yet it gestures toward a genuinely different philosophy of treatment.